Blackstone Life Sciences VI (LUX) SCSp — Form D/A

Blackstone Life Sciences VI (LUX) SCSp of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-12-09. $3.6B was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Joseph BarattaExecutive OfficerNew York, NY
Mathias G FavettoExecutive OfficerNew York, NY
John G FinleyExecutive OfficerNew York, NY
Nicholas G GalakatosExecutive OfficerNew York, NY
Elsa G GelinExecutive OfficerNew York, NY
Ilan G HalalExecutive OfficerNew York, NY
Eric G LiawExecutive OfficerNew York, NY
Robert G LiptakExecutive OfficerNew York, NY
Nentcho G NentchevExecutive OfficerNew York, NY
Alicia NovakExecutive OfficerNew York, NY
Chris G PlaccaExecutive OfficerNew York, NY
Victoria G PortnoyExecutive OfficerNew York, NY
Omar G RehmanExecutive OfficerNew York, NY
Christopher G StrianoExecutive OfficerNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.PromoterNew York, NY
n/a Blackstone Life Sciences Associates VI (LUX) S.a r.l.PromoterGrand Duchy of Luxembourg, N4
n/a BXLS VI L.L.C.PromoterNew York, NY
Eric LiawRelated PersonNew York, NY
Christopher StrianoRelated PersonNew York, NY
Joseph BarattaRelated PersonNew York, NY
Alicia NovakRelated PersonNew York, NY
n/a BXLS VI L.L.C.Related PersonNew York, NY
n/a Blackstone Life Sciences Associates VI (LUX) S.a r.l.Related PersonGrand Duchy of Luxembourg, N4
n/a Blackstone Life Sciences Associates VI L.P.Related PersonNew York, NY
Nentcho NentchevRelated PersonNew York, NY

Other filings by this issuer (3)

FiledFormOfferingSold
2026-04-02D/A$6.3B$6.3B
2025-10-08D/A$3.3B
2024-12-17D

More